Title : A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy.

Pub. Date : 2021 Jul

PMID : 33069665






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A Nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy. Anthracyclines erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 These results supported that the nine-lncRNA signature was a robust and effective model in predicting DRFS of patients with HER2-negative breast cancer following taxane and anthracycline-based neoadjuvant chemotherapy. Anthracyclines erb-b2 receptor tyrosine kinase 2 Homo sapiens